|
Volumn 52, Issue 5, 2007, Pages 1214-1218
|
Recommendations for toxicological investigation of drug impaired driving
|
Author keywords
Automobile driving; Driving under the influence of drugs; Drug; Forensic science; Impaired; Impaired performance
|
Indexed keywords
ALPRAZOLAM;
AMITRIPTYLINE;
CANNABIS;
CARISOPRODOL;
CENTRAL DEPRESSANT AGENT;
CENTRAL STIMULANT AGENT;
CLONAZEPAM;
COCAINE;
CODEINE;
DEXTROPROPOXYPHENE;
DIAZEPAM;
DIPHENHYDRAMINE;
HYPNOTIC AGENT;
LYSERGIDE;
MEPROBAMATE;
METHADONE;
METHAMPHETAMINE;
MORPHINE;
MUSCLE RELAXANT AGENT;
NARCOTIC ANALGESIC AGENT;
OXAZEPAM;
OXYCODONE;
PHENCYCLIDINE;
PHENYTOIN;
SECOBARBITAL;
TEMAZEPAM;
TETRAHYDROCANNABINOLIC ACID;
TOPIRAMATE;
TRAZODONE;
UNINDEXED DRUG;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRIVING ABILITY;
DRUG BLOOD LEVEL;
DRUG SCREENING;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
TOXICOLOGICAL PARAMETERS;
ALCOHOL DRINKING;
AUTOMOBILE DRIVING;
CENTRAL NERVOUS SYSTEM AGENTS;
CHROMATOGRAPHY, GAS;
FORENSIC TOXICOLOGY;
HUMANS;
IMMUNOASSAY;
LABORATORIES;
NARCOTICS;
QUESTIONNAIRES;
SUBSTANCE ABUSE DETECTION;
SUBSTANCE-RELATED DISORDERS;
UNITED STATES;
|
EID: 34548319334
PISSN: 00221198
EISSN: 15564029
Source Type: Journal
DOI: 10.1111/j.1556-4029.2007.00516.x Document Type: Conference Paper |
Times cited : (45)
|
References (6)
|